Adjunctive Cilostazol Versus Double-Dose Clopidogrel After Drug-Eluting Stent Implantation-Reference-Cited by-同舟云学术

Adjunctive Cilostazol Versus Double-Dose Clopidogrel After Drug-Eluting Stent Implantation

Published:2013-09 Issue:9 Volume:6 Page:932-942
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Park Kyung Woo,Kang Si-Hyuck,Park Jin Joo,Yang Han-Mo,Kang Hyun-Jae,Koo Bon-Kwon,Park Byoung-Eun,Cha Kwang Soo,Rhew Jay Young,Jeon Hui-Kyoung,Shin Eun Seok,Oh Ju Hyeon,Jeong Myung-Ho,Kim Sanghyun,Hwang Kyung-Kuk,Yoon Jung-Han,Lee Sung Yun,Park Tae-Ho,Moon Keon Woong,Kwon Hyuck-Moon,Chae In-Ho,Kim Hyo-Soo

Funder

Innovative Research Institute for Cell Therapy

Seoul National University Hospital

Boston Scientific Korea

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference38 articles.

1. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis;Sibbing;J Am Coll Cardiol,2009

2. Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation;Price;Eur Heart J,2008

3. Point-of-Care Measurement of Clopidogrel Responsiveness Predicts Clinical Outcome in Patients Undergoing Percutaneous Coronary Intervention